Fibrogen, Inc. v. Akebia Therapeutics, Inc.

136 S. Ct. 24, 192 L. Ed. 2d 995, 84 U.S.L.W. 3100, 2015 U.S. LEXIS 4665, 2015 WL 5145778
Supreme Court of the United States·Decided September 2, 2015·No. No. 15A252.·Published

Opinion

Application for stay presented to Justice KENNEDY and by him referred to the Court denied. Order heretofore entered by Justice KENNEDY vacated.

Free access — add to your briefcase to read the full text and ask questions with AI

Fibrogen, Inc. v. Akebia Therapeutics, Inc., 136 S. Ct. 24, 192 L. Ed. 2d 995, 84 U.S.L.W. 3100, 2015 U.S. LEXIS 4665, 2015 WL 5145778 (U.S. 2015).

136 S. Ct. 24 (Fibrogen, Inc. v. Akebia Therapeutics, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.